Pembrolizumab improves EFS in TNBC
Crossref DOI link: https://doi.org/10.1038/s41571-022-00614-4
Published Online: 2022-02-25
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2022-02-25
Version of Record valid from 2022-02-25
Article History
First Online: 25 February 2022